The manifestation of this ‘latent autoimmune diabetes in adulthood’ (LADA) is clinically defined by (1) an adult age of onset, (2) at least one diabetes-associated autoantibody, and (3) the lack of requisite insulin treatment for at least 6 months after diagnosis. The gene discussed is INS; the disease is diabetes mellitus.